Mathieu Bakhoum Lab
Bridging ophthalmology and cancer research
Uveal melanoma
We strive to understand the drivers of uveal melanoma metastasis, and develop novel therapeutic targets.
Retinal biomarkers of cardiovasuclar disease
We idenitified RIPLs, which are biomarkers to detect underlying cardiovascular disease.
In the News
News and Media coverage of our work.
The team
Publications
* Bakhoum MF et al. Loss of Polycomb Repressive Complex 1 activity and chromosomal instability drive uveal melanoma progression. Nature Communications (2021).
* Long C et al. Prevalence of subclinical retinal ischemia in cardiovascular disease - a hypothesis driven study. EClinical Medicine (2021).
* Bakhoum MF et al. BAP1 methylation: a prognostic marker of uveal melanoma metastasis. NPJ Precision Oncology (2021).
Our laboratory is located within the Yale School of Medicine Campus
Locations
Funding Sources
